Skip to main content

8110 Gatehouse Road, Falls Church, VA 22042

Implantable Cardioverter Defibrillator (ICD)

An implantable cardioverter defibrillator (ICD) is a device that monitors and moderates your heart rate. It uses batteries to send electric signals to a heart that’s beating too slow, similar to a pacemaker. The device can detect the arrhythmia and deliver a jolt of electricity to return your heartbeat back to a normal rhythm.

Inova offers two options:

New subcutaneous implantable cardioverter defibrillator (S-ICD)

Inova uses the Boston Scientific S-ICD® System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest. We are proud to say that an Inova patient received the first such device in the Northern Virginia and DC metro area. This device offers the same lifesaving benefits of a traditional defibrillator, with the advantage of lower risks of complication since there are no electrodes or leads placed into the heart itself. However, it is only used for patients who do not also require a pacemaker for slow heart rhythms.

Traditional (transvenous) implantable cardioverter-defibrillator

With a traditional implantable cardioverter-defibrillator, an Inova cardiac surgeon places the device below the skin and connects it to the heart with electrodes.

How do implantable cardioverter defibrillators work?

This device is designed to deliver two levels of electrical energy. A low energy shock can convert a beating heart that is in an abnormal rhythm back to a normal heartbeat. A high energy shock is delivered if the arrhythmia is so severe that the heart is only quivering instead of beating. Read more about the history of these devices.,w1712

Conditions Treated by the ICD

Implantable cardioverter defibrillators (ICD) are advised in specific patients who are at risk for potentially fatal ventricular arrhythmias, an abnormal rhythm from the lower heart chambers which can cause the heart to pump less effectively. There may be other reasons why your physician advises placement of a pacemaker or ICD.

Read more about arrhythmia and atrial fibrillation (AFib) 

History of the ICD

The first ICD was approved for implantation in the United States in 1985. At that time, it was indicated only for patients who had a documented cardiac arrest or life-threatening arrhythmia. The implantation of these devices was difficult and required electrodes to be placed directly on the surface of the heart. The device itself had to be placed in the wall of the upper abdomen as it was too large to be placed in the chest.

By the early 1990's, the devices no longer required wiring directly on the heart, but allowed for wiring that went through the vein to the inside surface of the heart. This made the implant procedure much easier and the recovery much quicker (just overnight).

The technology further improved to allow the devices to be smaller, which allowed implantation of the device in the upper chest, like a pacemaker, rather in the abdomen.

Around this time, the first seminal studies of defibrillators were complete. These studies evaluated ICDs for patients who had not yet had a life-threatening arrhythmia, but were statistically likely to develop one. The first such study, MADIT, took patients with a weakened heart from coronary artery disease. All patients received best medical therapy. Half the patients received a defibrillator and half did not. The group that implanted a defibrillator lived longer. The second major study, called SCD-HeFT, took patients with a weakened heart from any cause. Again, the group that received a defibrillator lived longer. Since that time, CMS approved the ICD for use in patients at high risk for a cardiac arrest.

Over time, the technology of ICDs has improved. They are essentially implantable computers that keep track of a patient's heart rhythm by pacing (protect from slow heart rates) as well as treating fast rhythms. They can pace-terminated a fast rhythm called ventricular tachycardia without resorting to a shock. In fact, a patient could have a life-threatening arrhythmia, the device could detect and treat it, without the patient even knowing it. They last longer than they did a decade ago. They can pace and also pace both sides of the heart for those patients with conduction problems and would benefits from bi-ventricular pacing.